Clinical Trials Logo

Clinical Trial Summary

To detect frequency of acute kidney injury in critically ill children in Assuit university hospital. To detect associated AKI risk factors, severity and outcomes . To assess the value of use of renal Doppler ultrasound in AKI.


Clinical Trial Description

Critically ill child is defined as a child whose baseline state of health has significantly changed and whose life is at risk as a result of an illness or injury and they in big need for intensive care whether medicallyor surgically. Acute kidney injury (AKI) is characterized by a sudden and generally revertible renal function impairment , involving inability to maintain the homeostasis, and may or not be accompanied by reduced diuresis. (1) Acute kidney injury (AKI) is highly prevalent among hospitalized children, with incidence rates ranging from 5% in non-critically ill children to 50% in those admitted to pediatric emergency units (2). This disease is strongly associated with worse outcomes, including increased mortality, increased use of mechanical ventilation, and prolonged hospital stay (3). AKI prevalence due to sepsis ranges from 9% to 40%, involves poor prognosis, and is associated with a 70% mortality rate (4). Among critically ill renal impaired patients, about 6% the septic shock, is one of the main causes of AKI. may need renal replacement therapy (RRT), with a mortality rate increased by 50 to 80%, particularly associated with sepsis, septic shock, and multiple organ and systems dysfunction MODS (5). During the childhood, the main AKI causes are sepsis, nephrotoxic drugs, and renal ischemia in critically ill patients (1) .These patients, particularly those staying in intensive care units , are exposed to a number of conditions which may result in renal impairment ,thus significantly increasing the morbidity and mortality rate. (6). Among the main causes that should be mentioned : hypovolemia leading to hypoperfusion and consequent hypoxia; inflammatory and thrombotic events caused by bacteremia ; systemic inflammation from trauma, major surgeries, extracorporeal circulation ;use of vasodilator drugs such as phosphodiesterase inhibitors, sedatives, epidural blockade; vasopressors; and use of nephrotoxic drugs as aminoglycosides, amphotericin B, radiological contrasts, and drugs interfering with the renal hemodynamics such as angiotensin converting enzyme inhibitors and angiotensin II receptor blockers (3). In 2004, a consensus definition for AKI was proposed by the Acute Dialysis Quality Initiative (ADQI) : the RIFLE criteria (risk, injury ,failure, loss, end-stage renal disease) (7) .The adult-derived RIFLE definition was modified, and then applied and validated in pediatric patients and renamed as the pediatric RIFLE criteria. pRIFLE stratifies AKI from mild (RIFLE R, risk) to severe (RIFLE F, failure) based on changes in SCR or estimated creatinine clearance and urine output .Similar to adult studies AKI defined by these criteria was an independent risk factor for both increased hospital length of stay and mortality. Currently, the most widely used criteria for diagnosing and staging AKI is the Kidney Disease Improving Global Outcomes (KDIGO) criteria, which is based on acute changes in serum creatinine (sCr) and/or reduced urine output (UO) (8). These criteria have limitations, especially in children. Significant sCr elevations can be delayed 24 to 48 hours after a renal insult and are commonly seen only after at least 50% of renal function loss. In addition, children may have very low sCr levels at baseline, which can make it difficult to identify relative increases when values remain within normal ranges. To overcome these limitatio, point-of-care ultrasonography has been proposed as a reliable and safe method to both diagnose and predict the occurrence of AKI in ICU patients (8). The AKI diagnosis methods include: clinical evaluation of the urine output and laboratory tests as urine analysis, blood urea nitrogen, and creatinine, however with low sensitivity and specificity.(9). Biomarkers for early AKI detection are currently under investigation, among them neutrophil gelatinase associated lipocalin (NGAL), cystatin C, interleukin 18, and kidney injury molecule-1(KIM1). Although these markers have good sensitivity and specificity, they are not routinely used due to their low availability and high costs(10). So there is a need for a method valid ,early, simple for early detection of AKI. Renal arterial Doppler-based parameters, such as renal resistive index (RRI) or renal pulsatility index (RPI), are rapid, noninvasive, and repeatable variables that may be promising for early AKI detection. Because it reflects resistance to blood flow, lower RRI values are associated with better renal perfusion, while increased values are associated with progression to ATN (11). However, there is a lack of evidence supporting the use of this technique in PICU. Therefore, this study aims to assess the accuracy of renal arterial Doppler ultrasound (RDU) to predict AKI in mechanically ventilated children. The complement system, which is a part of the innate immune system, is involved in mechanism of AKI , and thus could present a unifying therapeutic target in the pathophysiology of AKI development in children who are critically ill. The complement cascade is made up of three activation pathways: classic, alternative, and lectin. These three pathways feed into the "terminal complement cascade." These pathways generate protein fragments that can be quantified to determine the level of complement activation in each pathway in a given disease: C4a (classic and lectin pathways), Factors Ba and Bb (alternative pathway), C3a (all three pathways), and sC5b-9 (terminal pathway). The kidney is particularly susceptible to complement activation because complement proteins are concentrated in the kidney via glomerular filtration and activation is promoted via the kidney's acidic environment and ammonia synthesis (12). Complement factors have been shown to be instrumental in the pathogenesis of AKI in basic science models of sepsis and ischemia reperfusion injury (13,14). All three pathways have been implicated in the pathogenesis of a wide variety of kidney diseases (11,15,16). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06202326
Study type Observational
Source Assiut University
Contact Nardeen Elway, assistant lecturer
Phone 01212810204
Email nardeenchristdd@gmail.com
Status Not yet recruiting
Phase
Start date April 2024
Completion date June 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05538351 - A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Completed NCT03938038 - Guidance of Ultrasound in Intensive Care to Direct Euvolemia N/A
Recruiting NCT05805709 - A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial N/A
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Recruiting NCT05897840 - Continuous Central Venous Oxygen Saturation Measurement as a Tool to Predict Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients N/A
Recruiting NCT04986137 - Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis
Terminated NCT04293744 - Acute Kidney Injury After Cardiac Surgery N/A
Completed NCT04095143 - Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
Not yet recruiting NCT06026592 - Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
Not yet recruiting NCT06064305 - Transcriptional and Proteomic Analysis of Acute Kidney Injury
Terminated NCT03438877 - Intensive Versus Regular Dosage For PD In AKI. N/A
Terminated NCT03305549 - Recovery After Dialysis-Requiring Acute Kidney Injury N/A
Completed NCT05990660 - Renal Assist Device (RAD) for Patients With Renal Insufficiency Undergoing Cardiac Surgery N/A
Completed NCT04062994 - A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
Terminated NCT02860130 - Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT) Phase 3
Completed NCT06000098 - Consol Time and Acute Kidney Injury in Robotic-assisted Prostatectomy
Not yet recruiting NCT05548725 - Relation Between Acute Kidney Injury and Mineral Bone Disease
Completed NCT02665377 - Prevention of Akute Kidney Injury, Hearttransplant, ANP Phase 3
Terminated NCT03539861 - Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients N/A